Sorted By:

Relevance


New Avalere study: Health plan formularies continue to suggest bias against individuals with certain health conditions

PhRMA  |  Blog Post

Learn more about this and other policy solutions to engage and empower consumers here.
http://catalyst.phrma.org/new-avalere-study-health-plan-formularies-continue-to-suggest-bias-against-individuals-with-certain-health-conditions

World Asthma Day: New Hope for Millions with Asthma

PhRMA  |  Blog Post

PhRMA’s From Hope to Cures has resources dedicated to increasing awareness about asthma as well as information about new treatments targeting this chronic condition.
http://catalyst.phrma.org/world-asthma-day-new-hope-for-millions-with-asthma

PhRMA Launches New “Share the Savings” Campaign to Urge Payers to Share Negotiated Discounts with Patients  

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/phrma-launches-new-share-the-savings-campaign-to-urge-payers-to-share-negotiated-discounts-with-patients

ICYMI: New Commonwealth Fund Study Shows Health Insurance Does Not Always Translate to Affordable Care

PhRMA  |  Blog Post

Get ABC and other updates here.
http://catalyst.phrma.org/new-commonwealth-fund-study-shows-health-insurance-does-not-always-translate-to-affordable-care

In biopharmaceutical research, if at first you don’t succeed, try again

PhRMA  |  Blog Post

With over 7,000 new medicines currently in development, patients today have more hope for a better quality of life.
http://catalyst.phrma.org/in-biopharmaceutical-research-if-at-first-you-dont-succeed-try-again

Cancer treatments got gentler, yet kids’ survival improved

From Hope To Cures  |  From Our Network

"We have actually reduced treatment, reduced therapy," and yet improved survival, he said.
http://www.fromhopetocures.org/cancer-treatments-got-gentler-yet-kids-survival-improved

This is not a special effect: New video shows the destruction of a rogue cell

PhRMA  |  Blog Post

Learn more about the fight against rheumatoid arthritis at GoBoldly.com and Innovation.org.
http://catalyst.phrma.org/this-is-not-a-special-effect-new-video-shows-the-destruction-of-a-rogue-cell

Key Facts Card

PhRMA  |  Fact Sheet

Relentless scientific inquiry in drug development is shifting the odds in the fight against some of the world’s most challenging diseases. Industry facts from research and development to value of medicines to economic impact are outlined in the Fact Sheet below....
http://www.phrma.org/fact-sheet/key-facts-card

New report highlights need to speed patent examination

PhRMA  |  Blog Post

The United Kingdom’s Intellectual Property Office estimated that combined losses from each year of backlog in the U.S.
http://catalyst.phrma.org/new-report-highlights-need-to-speed-patent-examination

YMCA Healthy Kids Day: Promoting Childhood Wellness

PhRMA  |  Blog Post

They are crucial to protecting our children so that they can have fun at events like the YMCA’s Healthy Kids Day.
http://catalyst.phrma.org/ymca-healthy-kids-day-promoting-childhood-wellness

PhRMA Announces Promotions of Key Federal Affairs Staff

PhRMA  |  Press Release

PhRMA Internet Address: http://www.phrma.orgFor information on how innovative medicines save lives, visit: http://www.innovation.orgFor information on the Partnership for Prescription Assistance, visit: http://www.pparx.orgFor more information on public health emergencies, visit http://www.rxresponse.orgFor information on the danger of imported drugs, visit: http://www.buysafedrugs.info
http://www.phrma.org/press-release/phrma-announces-promotions-of-key-federal-affairs-staff

New Chart Pack: Biopharmaceuticals in Government Programs

PhRMA  |  Blog Post

  Medicines in Medicare Part D Beneficiaries Save Through Plan Competition and Manufacturer Negotiations   Medicines in Medicare Part B Program Spending on Prescription Medicines Accounted for About 8% of Part B Spending in 2012   Medicines in Medicaid On Average, About 60% of the Initial Cost of Brand Medicines is Returned to States Through Rebates   Medicines in Veterans Affairs VA Formulary Covers Fewer Drugs Than Part D Medicines in 340B Without Significant Reforms 340B Will Continue to Grow as Uninsured Rate Declines Check out PhRMA’s other chart pack resources here and check back with our Medicare Monday series and 340B Spotlight as we take a deeper look at some of these charts in the coming weeks.
http://catalyst.phrma.org/new-chart-pack-biopharmaceuticals-in-government-programs

Medicines in Development for Arthritis 2014 Report

PhRMA  |  Report

New medicines today in the research and development pipeline offer hope of reducing the human and economic costs of the many musculoskeletal disorders affecting Americans.
http://www.phrma.org/report/medicines-in-development-for-arthritis-2014-report

FDA Modernization

PhRMA  |  From PhRMA

Solutions
http://www.phrma.org/advocacy/research-development/fda-modernization

New Avalere Study: Health Plan Bias

PhRMA  |  Fact Sheet

Despite warnings from the Centers for Medicare & Medicaid Services (CMS) that requiring high cost sharing for all or most medications to treat a condition may be discriminatory, new data from Avalere show some health plans are continuing to engage in this practice.
http://www.phrma.org/fact-sheet/new-avalere-study-health-plan-bias

Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

PhRMA  |  Press Release

Scangos was appointed CEO of Biogen Idec in June 2010.
http://www.phrma.org/press-release/pfizer-s-ian-read-becomes-phrma-board-chairman-ken-frazier-george-scangos-assume-new-posts

New First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
http://www.phrma.org/press-release/new-first-of-its-kind-study-shows-growing-share-of-medicine-list-prices-going-to-rebates-and-supply-chain

New Policy Solutions for Innovative Treatment Delivery

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $51.2 billion in 2014 alone.
http://www.phrma.org/press-release/phrma-releases-new-policy-solutions-for-delivering-innovative-treatments-to-patients

New prostate cancer treatment will get its first test in Omaha

From Hope To Cures  |  From Our Network

The society estimates that 220,800 new cases were found in 2015 and that 27,540 men died of the disease.
http://www.fromhopetocures.org/new-prostate-cancer-treatment-will-get-its-first-test-in-omaha

New Medicines in Development for Women

PhRMA  |  Video

America’s pharmaceutical research and biotechnology companies continue making exciting progress in the search for new cures and treatments for diseases of special concern to women.
http://www.phrma.org/video/new-medicines-in-development-for-women

The risks of counterfeit imported medicines

PhRMA  |  Blog Post

Get the facts about drug importation here.
http://catalyst.phrma.org/the-risks-of-counterfeit-imported-medicines

PhRMA Statement Regarding Prescription Drug User Fee Act Reauthorization

PhRMA  |  Press Release

PhRMA members alone invested an estimated $49.5 billion in 2011 in discovering and developing new medicines.
http://www.phrma.org/press-release/phrma-statement-regarding-prescription-drug-user-fee-act-reauthorization2

Collaboration Is Key in Researching and Developing New Medicines

Chartpack  |  From Our Network

The Accelerating Medicines Partnership, Biomarkers Consortium and Lung Cancer Master Protocol are a few examples of current collaborative efforts.
http://chartpack.phrma.org/biophrma-chartpack/research-and-development/collaboration-is-key-in-researching-and-developing-new-medicines

Rare Disease Day Should Last All Year

PhRMA  |  Blog Post

For example, America's biopharmaceutical research companies are today working on more than 400 new medicines to help treat a wide variety of rare diseases.
http://catalyst.phrma.org/rare-disease-day-should-last-all-year

New Survey: Patients’ share of health care costs continues to grow

PhRMA  |  Blog Post

Clear information about out-of-pocket costs can help patients make better health coverage decisions.
http://catalyst.phrma.org/new-survey-patients-share-of-health-care-costs-continue-to-grow

You have reviewed the first 150 results out of 1864. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next